Literature DB >> 3379144

Lithium in the treatment of bipolar disorders associated with epilepsy: an open study.

S Shukla1, S Mukherjee, P Decina.   

Abstract

Eight DSM-III bipolar patients with seizure disorders were treated in an open study evaluating the effects of maintenance lithium treatment on affective relapses and clinical seizure activity. Lithium was effective in preventing the recurrence of affective episodes without worsening seizure frequency in patients with active seizures and did not induce seizures in those whose seizures were in remission. One patient showed remission of both affective and seizure symptoms on lithium alone. Lithium appears to be safe and effective in bipolar disorders associated with epilepsy and may have an anticonvulsant effect in some patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379144

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

2.  Lithium therapy in comorbid temporal lobe epilepsy and cycloid psychosis.

Authors:  Paul Brown; Sridhar Kashiviswanath; Alison Huynh; Naveen Allha; Ken Piaggio; Saddichha Sahoo; Ankur Gupta
Journal:  Oxf Med Case Reports       Date:  2016-12-01

3.  Lithium Treatment Is Safe in Children With Intellectual Disability.

Authors:  Junying Yuan; Juan Song; Dengna Zhu; Erliang Sun; Lei Xia; Xiaoli Zhang; Chao Gao; Galila Agam; Xiaoyang Wang; Klas Blomgren; Changlian Zhu
Journal:  Front Mol Neurosci       Date:  2018-11-22       Impact factor: 5.639

4.  Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus.

Authors:  Tobias Engel; Raquel Gómez-Sintes; Mariana Alves; Eva M Jimenez-Mateos; Marta Fernández-Nogales; Amaya Sanz-Rodriguez; James Morgan; Edward Beamer; Alberto Rodríguez-Matellán; Mark Dunleavy; Takanori Sano; Jesus Avila; Miguel Medina; Felix Hernandez; José J Lucas; David C Henshall
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 5.  GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration.

Authors:  Tomasz Jaworski; Ewa Banach-Kasper; Katarzyna Gralec
Journal:  Neural Plast       Date:  2019-05-02       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.